Eli Lilly and Company (NYSE:LLY) developer of pharmaceutical products, is expected to report third quarter earnings results, before market open, on Tuesday 27th October 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 1.71 per share.
Looking ahead, the full year income are expected at $ 7.28 per share on the revenues of $ 23909.30 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 23,700.00 million ~ $ 24,200.00 million, where as bottomline are predicted in a range of $ 7.20 ~ $ 7.40 per share
Click Here For More Historical Outlooks Of Eli Lilly and Company
Previous Quarter Performance
Eli Lilly and Company disclosed income for the second quarter of $ 1.89 per share, from the revenue of $ 5,499.00 million. The quarterly earnings swell 26.00 percent while revenues down 2.44 percent compared with the same quarter last year.
The consensus estimates are income of $ 1.56 per share from $ 5764.22 million in revenue. The bottom line results beat street analysts by $ 0.33 or 21.15 percent, at the same time, top line results fell short of analysts by $ 265.22 million or 4.6 percent.
Stock Performance
Shares of Eli Lilly and Company traded up $ 0.73 or 0.52 percent on Friday, reaching $ 142.38 with volume of 2.34 million shares. Eli Lilly and Company has traded high as $ 144.70 and has cracked $ 141.72 on the downward trend
According to the previous trading day, closing price of $ 142.38, representing a 28.18 % increase from the 52 week low of $ 110.51 and a 17.04 % decrease over the 52 week high of $ 170.75.
The company has a market capital of $ 136.18 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
Recent Analyst recommendations
- On 16th October 2020, maintained by JPMorgan Chase & Co. at Overweight rating, with $ 200.00 target price.
- On 29th September 2020, initiated by Berenberg Bank at Hold rating, with $ 144.00 target price.
- On 3rd September 2020, upgraded by Morgan Stanley to Overweight from Equal-Weight rating.
Conference Call
Eli Lilly and Company will be hosting a conference call at 9:00 AM eastern time on 27th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.lilly.com
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.
